Turkish President Tayyip Erdogan said on Wednesday that an opposition political campaign inquiring over the sale of some $128 billion in the central bank's foreign reserves was "outright treason against the people of Turkey."
Emerging European assets were
mixed on Wednesday morning as global investors braced for a new
challenge from the COVID-19 pandemic, with Czech assets
successfully weathering a diplomatic storm with ...
* Graphic: World FX rates http://tmsnrt.rs/2egbfVh. * Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv. By Julien Ponthus. Sterling held its ground against the dollar on Wednesday as traders assumed a rise in inflation in March would have little impact on monetary policy and waited for crucial activity and retail sales data due at the end of the week.
* The Turkish lira worst EMEA performer. * Putin speech awaited amid increased geopolitical tensions. * South African rand flat after inflation data. By Ambar Warrick. Emerging market stocks tumbled on Wednesday as a second wave of COVID-19 infections threatened further disruption in major economies, while Russia's rouble weakened ahead of a speech on economic growth by President Vladmir Putin.
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E. The U.S. dollar firmed on Wednesday, rising from a seven-week low hit overnight, as broad-based weakness in stock markets triggered by a resurgence of COVID-19 cases in countries from India to Japan fuelled renewed appetite for the greenback.
The dollar languished on Wednesday, hovering just above a seven-week low with subdued U.S. bond yields reducing the currency's yield appeal. The safe-haven greenback got some respite from a pullback in world stocks from record highs as flare ups in coronavirus infections from India to Canada soured the outlook for a quick global recovery.
Most Latin American currencies fell on
Tuesday as the dollar strengthened off lows, with falling oil
prices knocking currencies of Colombia and Mexico.
Chile's peso, meanwhile, rose 0.5% to ...
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
